Publication Cover
Chronobiology International
The Journal of Biological and Medical Rhythm Research
Volume 36, 2019 - Issue 9
539
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice

ORCID Icon, , , , &
Pages 1194-1207 | Received 30 Oct 2018, Accepted 27 May 2019, Published online: 14 Jun 2019

References

  • Ago Y, Tanaka T, Ota Y, Kitamoto M, Imoto E, Takuma K, Matsuda T. 2014. Social crowding in the night-time reduces an anxiety-like behavior and increases social interaction in adolescent mice. Behav Brain Res. 270:37–46. doi:10.1016/j.bbr.2014.04.047. PMID: 24803212.
  • Akiyoshi J, Kuranaga H, Tsuchiyama K, Nagayama H. 1989. Circadian rhythm of serotonin receptor in rat brain. Pharmacol Biochem Behav. 32:491–493. doi:10.1016/0091-3057(89)90186-X. PMID:2727009.
  • Alvarez J-C, Bothua D, Collignon I, Advenier C, Spreux-Varoquaux O. 1998. Determination of fluoxetine and its metabolite norfluoxetine in serum and brain areas using high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Biomed Sci App. 707:175–180. doi:10.1016/S0378-4347(97)00588-4. PMID:9613947.
  • Anderson IM. 2001. Meta-analytical studies on new antidepressants. Br Med Bull. 57:161–178. doi:10.1093/bmb/57.1.161. PMID:11719915.
  • Anttila SA, Leinonen EV. 2001. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 7:249–264. doi:10.1111/j.1527-3458.2001.tb00198.x. PMID:11607047.
  • Au J, Reece J. 2017. The relationship between chronotype and depressive symptoms: A meta-analysis. J Affect Disord. 218:93–104. doi:10.1016/j.jad.2017.04.021. PMID:28463712.
  • Avery DH, Wildschiødtz G, Rafaelsen OJ. 1982. Nocturnal temperature in affective disorder. J Affect Disord. 4:61–71. doi:10.1016/0165-0327(82)90020-9. PMID:6461688.
  • Bai F, Li X, Clay M, Lindstrom T, Skolnick P. 2001. Intra- and interstrain differences in models of “behavioral despair”. Pharmacol Biochem Behav. 70:187–192. doi:10.1016/S0091-3057(01)00599-8. PMID:11701187.
  • Basso AM, Gallagher KB, Bratcher NA, Brioni JD, Moreland RB, Hsieh GC, Drescher K, Fox GB, Decker MW, Rueter LE. 2005. Antidepressant-like effect of D2/3 receptor-, but not D4 receptor-activation in the rat forced swim test. Neuropsychopharmacology. 30:1257. doi:10.1038/sj.npp.1300677. PMID:15688083.
  • Bhaskaran D, Radha E. 1984. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age. Exp Gerontol. 19:153–170. doi:10.1016/0531-5565(84)90034-2. PMID:6479252.
  • Bicakova-Rocher A, Gorceix A, Reinberg A, Ashkenazi II, Ticher A. 1996. Temperature rhythm of patients with major affective disorders: reduced circadian period length. Chronobiol Int. 13:47–57. doi:10.3109/07420529609040841. PMID:8761936.
  • Borsini F, Lecci A, Stasi MA, Pessia M, Meli A. 1990. Seasonal and circadian variations of behavioural response to antidepressants in the forced swimming test in rats. Behav Pharmacol. 1:395–401. doi:10.1097/00008877-199000150-00001. PMID:11175424.
  • Bourin M, Mocaer E, Porsolt R. 2004. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci. 29:126–133. PMID:15069466.
  • Castaneda TR, de Prado BM, Prieto D, Mora F. 2004. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res. 36:177–185. doi:10.1046/j.1600-079X.2003.00114.x. PMID:15009508.
  • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JPT, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, et al. 2009. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet. 373:746–758. doi:10.1016/S0140-6736(09)60046-5. PMID:19185342.
  • Cornelissen G. 2014. Cosinor-based rhythmometry. Theor Biol Med Model. 11:16. doi:10.1186/1742-4682-11-16. PMID:24725531.
  • Cryan JF, Mombereau C, Vassout A. 2005. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev. 29:571–625. doi:10.1016/j.neubiorev.2005.03.009. PMID:15890404.
  • De Boer T, Ruigt GSF, Berendsen HHG. 1995. The α2-selective adrenoceptor antagonist org 3770 (mirtazapine, Remeron®) enhances noradrenergic and serotonergic transmission. Hum Psychopharmacol: Clin Exp. 10:S107–S118.
  • Dutta A, McKie S, Deakin JFW. 2015. Ketamine and other potential glutamate antidepressants. Psychiatry Res. 225:1–13. doi:10.1016/j.psychres.2014.10.028. PMID:25467702.
  • Einarson TR, Arikian SR, Casciano J, Doyle JJ. 1999. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: a meta-analysis of randomized controlled trials. Clin Ther. 21:296–308. doi:10.1016/S0149-2918(00)88287-9. PMID:10211533.
  • Gomes KM, Souza RP, Valvassori SS, Réus GZ, Inácio CG, Martins MR, Comim CM, Quevedo J. 2009. Chronic methylphenidate-effects over circadian cycle of young and adult rats submitted to open-field and object recognition tests. Curr Neurovascul Res. 6:259–265. doi:10.2174/156720209789630357. PMID:19807653.
  • Holladay JW, Dewey MJ, Yoo SD. 1998. Pharmacokinetics and antidepressant activity of fluoxetine in transgenic mice with elevated serum alpha-1-acid glycoprotein levels. Drug Metab Dispos. 26:20–24. PMID:9443847.
  • Holliday SM, Benfield P. 1995. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs. 49:280–294. doi:10.2165/00003495-199549020-00010. PMID:7729333.
  • Horst WD, Preskorn SH. 1998. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord. 51:237–254. doi:10.1016/S0165-0327(98)00222-5. PMID:10333980.
  • Huynh TN, Krigbaum AM, Hanna JJ, Conrad CD. 2011. Sex difference and phase of light cycle modify chronic stress effects on anxiety and depressive-like behavior. Behav Brain Res. 222:212–222. doi:10.1016/j.bbr.2011.03.038. PMID: 21440009.
  • Jones N, King SM. 2001. Influence of circadian phase and test illumination on pre-clinical models of anxiety. Physiol Behav. 72:99–106. doi:10.1016/S0031-9384(00)00388-7. PMID:11239986.
  • Kafka MS, Wirz-Justice A, Naber D, Moore RY, Benedito MA. 1983. Circadian rhythms in rat brain neurotransmitter receptors. Fed Proc. 42:2796–2801. PMID:6135629.
  • Kanda Y. 2013. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48:452–458. doi:10.1038/bmt.2012.244. PMID:23208313.
  • Kawai H, Kodaira N, Tanaka C, Ishibashi T, Kudo N, Kawashima Y, Mitsumoto A. 2018b. Time of administration of acute or chronic doses of imipramine affects its antidepressant action in rats. J Circadian Rhythms. 16:5. doi:10.5334/jcr.156. PMID: 30210565.
  • Kawai H, Machida M, Ishibashi T, Kudo N, Kawashima Y, Mitsumoto A. 2018a. Chronopharmacological analysis of antidepressant activity of a dual-action serotonin noradrenaline reuptake inhibitor (SNRI), Milnacipran, in Rats. Biol Pharm Bull. 41:213–219. doi:10.1248/bpb.b17-00733. PMID:29386481.
  • Kohsaka A, Das P, Hashimoto I, Nakao T, Deguchi Y, Gouraud SS, Waki H, Muragaki Y, Maeda M. 2014. The circadian clock maintains cardiac function by regulating mitochondrial metabolism in mice. PLoS One. 9:e112811. doi:10.1371/journal.pone.0112811. PMID:25389966.
  • Lemmer B, Górka Z, Gottheiner H, Lang P. 1986. Effects of imipramine on circadian rhythms in the beta-receptor-effector system and in the motor activity of rats. Ann Rev Chronopharmacol. 3:343–346.
  • Lemmer B, Holle L. 1991. Chronopharmacokinetics of imipramine and desipramine in rat forebrain and plasma after single and chronic treatment with imipramine. Chronobiol Int. 8:176–185. doi:10.3109/07420529109063924. PMID:1794155.
  • Lévi F, Zidani R, Misset J-L. 1997. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet. 350:681–686. doi:10.1016/S0140-6736(97)03358-8. PMID:9291901.
  • Liu X, Gershenfeld HK. 2001. Genetic differences in the tail-suspension test and its relationship to imipramine response among 11 inbred strains of mice. Biol Psychiatry. 49:575–581. doi:10.1016/S0006-3223(00)01028-3. PMID:11297714.
  • Lucki I, Dalvi A, Mayorga AJ. 2001. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology. 155:315–322. doi:10.1007/s002130100694. PMID:11432695.
  • Martin P, Massol J, Colin JN, Lacomblez L, Puech AJ. 1990. Antidepressant profile of bupropion and three metabolites in mice. Pharmacopsychiatry. 23:187–194. doi:10.1055/s-2007-1014505. PMID:2116631.
  • Masuo Y, Matsumoto Y, Morita S, Noguchi J. 1997. A novel method for counting spontaneous motor activity in the rat. Brain Res Prot. 1:321–326. doi:10.1016/S1385-299X(97)00005-6. PMID:9384810.
  • McGlashan EM, Drummond SPA, Cain SW. 2018. Evening types demonstrate reduced SSRI treatment efficacy. Chronobiol Int. 35:1175–1178. doi:10.1080/07420528.2018.1458316. PMID:29658803.
  • Merikanto I, Lahti T, Kronholm E, Peltonen M, Laatikainen T, Vartiainen E, Salomaa V, Partonen T. 2013. Evening types are prone to depression. Chronobiol Int. 30:719–725. doi:10.3109/07420528.2013.784770. PMID:23688117.
  • Mochizuki D, Tsujita R, Yamada S, Kawasaki K, Otsuka Y, Hashimoto S, Hattori T, Kitamura Y, Miki N. 2002. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. Psychopharmacology. 162:323–332. doi:10.1007/s00213-002-1111-5. PMID:12122491.
  • Moffoot APR, O’Carroll RE, Bennie J, Carroll S, Dick H, Ebmeier KP, Goodwin GM. 1994. Diurnal variation of mood and neuropsychological function in major depression with melancholia. J Affect Disord. 32:257–269. doi:10.1016/0165-0327(94)90090-6. PMID:7897090.
  • Muguruza C, Rodríguez F, Rozas I, Meana JJ, Urigüen L, Callado LF. 2013. Antidepressant-like properties of three new α2-adrenoceptor antagonists. Neuropharmacology. 65:13–19. doi:10.1016/j.neuropharm.2012.09.003. PMID:22982479.
  • Murrough JW, Abdallah CG, Mathew SJ. 2017. Targeting glutamate signalling in depression: progress and prospects. Nature Reviews Drug Discov. 16:472. doi:10.1038/nrd.2017.16. PMID: 28303025.
  • Nagayama H. 1999. Influences of biological rhythms on the effects of psychotropic drugs. Psychosom Med. 61:618–629. doi:10.1097/00006842-199909000-00006. PMID:10511012.
  • Nagayama H, Nagano K, Ikezaki A, Tashiro T. 1991. Double-blind study of the chronopharmacotherapy of depression. Chronobiol Int. 8:203–209. doi:10.3109/07420529109063927. PMID:1794158.
  • Nakano S, Hollister LE. 1983. Chronopharmacology of amitriptyline. Clin Pharmacol Ther. 33:453–459. doi:10.1038/clpt.1983.61. PMID:6831823.
  • O’Brien FE, Clarke G, Dinan TG, Cryan JF, Griffin BT. 2013. Human P-glycoprotein differentially affects antidepressant drug transport: relevance to blood–brain barrier permeability. Int J Neuropsychopharmacology. 16:2259–2272. doi:10.1017/S1461145713000692. PMID:23931269.
  • Ota Y, Ago Y, Tanaka T, Hasebe S, Toratani Y, Onaka Y, Hashimoto H, Takuma K, Matsuda T. 2015. Anxiolytic-like effects of restraint during the dark cycle in adolescent mice. Behav Brain Res. 284:103–111. doi:10.1016/j.bbr.2015.02.010. PMID:25687845.
  • Peroutka SJ, Snyder SH. 1980. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science. 210:88. doi:10.1126/science.6251550. PMID:6251550.
  • Philipp M, Marneros A. 1978. Chronobiology and its implications for pharmacotherapy of endogenous depression. Pharmakopsychiatr Neuropsychopharmakol. 11:235–240. doi:10.1055/s-0028-1094583. PMID:360248.
  • Poleszak E, Szopa A, Wyska E, Wośko S, Serefko A, Wlaź A, Pieróg M, Wróbel A, Wlaź P. 2015. The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life Sci. 136:13–18. doi:10.1016/j.lfs.2015.06.008. PMID:26135623.
  • Porsolt RD, Anton G, Blavet N, Jalfre M. 1978. Behavioural despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol. 47:379–391. doi:10.1016/0014-2999(78)90118-8. PMID:204499.
  • Quay WB. 1968. Differences in circadian rhythms in 5-hydroxytryptamine according to brain region. Am J Physiol. 215:1448–1453. doi:10.1152/ajplegacy.1968.215.6.1448. PMID:5723006.
  • Renard CE, Dailly E, David DJP, Hascoet M, Bourin M. 2003. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol. 17:449–455. doi:10.1046/j.1472-8206.2003.00160.x. PMID:12914547.
  • Richelson E, Nelson A. 1984. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther. 230:94. PMID:6086881.
  • Richetto J, Polesel M, Weber-Stadlbauer U. 2019. Effects of light and dark phase testing on the investigation of behavioral paradigms in mice: relevance for behavioural neuroscience. Pharmacol Biochem Behav. 178:19–29. doi:10.1016/j.pbb.2018.05.011. PMID:29782942.
  • Satoh Y, Kawai H, Kudo N, Kawashima Y, Mitsumoto A. 2006. Temperature rhythm reentrains faster than locomotor rhythm after a light phase shift. Physiol Behav. 88:404–410. doi:10.1016/j.physbeh.2006.04.017. PMID:16730361.
  • Slattery DA, Cryan JF. 2012. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc. 7:1009–1014. doi:10.1038/nprot.2012.044. PMID:22555240.
  • Steru L, Chermat R, Thierry B, Simon P. 1985. The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology. 85:367–370. doi:10.1007/BF00428203. PMID:3923523.
  • Tatsumi M, Groshan K, Blakely RD, Richelson E. 1997. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 340:249–258. doi:10.1016/S0014-2999(97)01393-9. PMID:9537821.
  • Tong YL. 1976. Parameter estimation in studying circadian rhythms. Biometrics. 32:85–94. doi:10.2307/2529340. PMID:1276369.
  • Tournel G, Houdret N, Hédouin V, Deveaux M, Gosset D, Lhermitte M. 2001. High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human serum. J Chromatogr B Biomed Sci Appl. 761:147–158. doi:10.1016/S0378-4347(01)00305-X. PMID:11587344.
  • Uhr M, Grauer MT, Holsboer F. 2003. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption. Biol Psychiatry. 54:840–846. doi:10.1016/S0006-3223(03)00074-X. PMID:14550684.
  • Usher RW, Beasley CM Jr., Bosomworth JC. 1991. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry. 52:134–136. PMID:2005078.
  • Ushijima K, Sakaguchi H, Sato Y, To H, Koyanagi S, Higuchi S, Ohdo S. 2005. Chronopharmacological study of antidepressants in forced swimming test of mice. J Pharmacol Exp Ther. 315:764–770. doi:10.1124/jpet.105.088849. PMID:16079297.
  • Voderholzer U, Valerius G, Schaerer L, Riemann D, Giedke H, Schwärzler F, Berger M, Wiegand M. 2003. Is the antidepressive effect of sleep deprivation stabilized by a three day phase advance of the sleep period? Eur Arch Psychiatry Clin Neurosci. 253:68–72. doi:10.1007/s00406-003-0408-7. PMID:12799743.
  • Wehr TA, Wirz-Justice A, Goodwin FK, Duncan W, Gillin JC. 1979. Phase advance of the circadian sleep-wake cycle as an antidepressant. Science. 206:710–713. doi:10.1126/science.227056. PMID:227056.
  • Williams NR, Schatzberg AF. 2016. NMDA antagonist treatment of depression. Curr Opin Neurobiol. 36:112–117. doi:10.1016/j.conb.2015.11.001. PMID:26687375.
  • Wong DT, Bymaster FP, Engleman EA. 1995. Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:411–441. doi:10.1016/0024-3205(95)00209-O. PMID:7623609.
  • Wong DT, Bymaster FP, Reid LR, Mayle DA, Krushinski JH, Robertson DW. 1993. Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacology. 8:337. doi:10.1038/npp.1993.33. PMID:8512621.
  • Wong SHY, Kranzler HR, Dellafera S, Fernandes R. 1994. Determination of fluvoxamine concentration in plasma by reversed-phase liquid chromatography. Biomed Chromatogr. 8:278–282. doi:10.1002/bmc.1130080605. PMID:7888729.
  • Yoo SD, Holladay JW, Fincher TK, Baumann H, Dewey MJ. 1996. Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein. J Pharmacol Exp Ther. 276:918–922. PMID:8786570.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.